This test detects IgA antibodies directed against Beta-2 Glycoprotein 1 (β2GPI), a plasma protein involved in regulating blood clot formation. These antibodies are part of the Antiphospholipid Antibody (aPL) family and are associated with Antiphospholipid Syndrome (APS) — an autoimmune condition that increases the risk of abnormal blood clots and pregnancy complications.
Diagnostic Value: The IgA form of β2GPI antibodies can help identify seronegative APS, in which IgG and IgM antibodies are absent but autoimmune clotting activity still exists.
Clinical Significance: Elevated IgA β2GPI antibodies may be linked to arterial or venous thrombosis and recurrent pregnancy loss. Testing for all three isotypes (IgA, IgG, IgM) provides a more complete picture of a patient’s clotting risk.
Symptom Correlation: Patients may present with deep vein thrombosis, stroke, or miscarriages related to impaired blood flow.
The Beta-2 Glycoprotein 1 IgA test enhances diagnostic sensitivity, ensuring no case of autoimmune-related clotting risk is overlooked.